Neulasta (pegfilgrastim), a new long-acting form of Neupogen (filgrastim)

April 2002

Amgen will soon launch Neulasta (pegfilgrastim), a new long-acting form of Neupogen (filgrastim). ...

Exclusive Subscriber Content

Best in class medication learning
Concise recommendations
Hundreds of practical resources

Subscribe Now Learn More

Login to access this content.

Login

Table of Contents

Pharmacies are setting up pharmaceutical care centers
Diabetes stronger warnings about Actos and heart failure
Diabetes metformin can lower vitamin B12 levels
Diabetes confused about the "sugar-free" candies marketed to patients with diabetes
Osteoporosis latest thinking on treating osteoporosis in postmenopausal women
Cardiology More patients will be taking Plavix (clopidogrel)
Multiple Sclerosis new interferon for MS called Rebif
Obesity Weight Loss new concerns about the safety of Meridia (sibutramine)
Obesity Weight Loss natural weight loss products
nocebo effect
Hematology Oncology Neulasta (pegfilgrastim), a new long-acting form of Neupogen (filgrastim)
Vaccines Lymerix is off the market
Vaccines current vaccine shortages
Alzheimer s Disease link between homocysteine levels and dementia
Practice Claritin will go OTC soon